Evidence map›Paper›PMID 29634627›Full record

ArticleMedical care2018

Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis.

Christine Y Lu, Robert B Penfold, Sengwee Toh, Jessica L Sturtevant, Jeanne M Madden, Gregory Simon, Brian K Ahmedani, Gregory Clarke, Karen J Coleman, Laurel A Copeland and 8 more

Abstract read
In one paragraph

Article in Medical care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 1 country.

Christine Y LuDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Robert B PenfoldDepartment of Health Services Research, Kaiser Permanente Washington Health Research Institute, University of Washington, Seattle, WA.
Sengwee TohDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Jessica L SturtevantDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Jeanne M MaddenDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Gregory SimonKaiser Permanente Washington Health Research Institute, Seattle, WA.
Brian K AhmedaniCenter for Health Policy and Health Services Research and Behavioral Health Services, Henry Ford Health System, Detroit, MI.
Gregory ClarkeCenter for Health Research, Kaiser Permanente Northwest, Portland, OR.
Karen J ColemanDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
Laurel A CopelandCenter for Applied Health Research, Baylor Scott & White Health jointly with Central Texas Veterans Health Care System, Temple, TX.
Yihe G DaidaCenter for Health Research, Kaiser Permanente Hawaii, Honolulu, HI.
Robert L DavisCenter for Biomedical Informatics, University of Tennessee Health Science Center, Memphis, TN.
Enid M HunkelerEmeritus, Division of Research, Kaiser Permanente, Oakland, CA.
Ashli Owen-SmithHealth Management & Policy, Georgia State University School of Public Health, Atlanta, GA.
Marsha A RaebelKaiser Permanente Colorado, Institute for Health Research, Denver, CO.
Rebecca RossomHealthPartners Institute, Bloomington, MN.
Stephen B SoumeraiDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA.
Martin KulldorffDepartment of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School and Brigham and Women's Hospital, Boston, MA.
Harvard University · USKaiser Permanente · USHarvard Pilgrim Health Care · USKaiser Permanente Center for Health Research · USBaylor Scott & White Health · USBehavioral Health Services · USHealthPartners · USKaiser Permanente Oakland Medical Center · USKaiser Permanente Washington Health Research Institute · USUniversity of Tennessee Health Science Center · USUniversity of Washington · US

Funding

SSRI's and SuicidalityU19MH092201 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI SIMON, GREGORY E. · 2010 to 2018
$19.5M
Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Advancing Geriatrics Infrastructure & Network Growth - Admin Supplement: Designing and Testing an Informatics Tool to Aid Prescribers in Reducing Anticholinergic Burden in Older AdultsR24AG045050 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GURWITZ, JERRY H · 2014 to 2017
$3.6M
Software for Near Real-Time Post-Market Drug and Vaccine Safety SurveillanceR01GM108999 · NIGMS · HARVARD PILGRIM HEALTH CARE, INC. · PI KULLDORFF, MARTIN · 2014 to 2017
$1.1M
A Study of Dog Adoption in Veterans with Posttraumatic Stress DisorderI21RX000809 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI STERN, STEPHEN L. · 2015 to 2015
–
NIA NIH HHS R24 AG045050NIDDK NIH HHS P30 DK092924NIGMS NIH HHS R01 GM108999NIMH NIH HHS U19 MH092201RRD VA I21 RX000809
6 · The paper itself

Abstract

backgroundNew health policies may have intended and unintended consequences. Active surveillance of population-level data may provide initial signals of policy effects for further rigorous evaluation soon after policy implementation.

objectiveThis study evaluated the utility of sequential analysis for prospectively assessing signals of health policy impacts. As a policy example, we studied the consequences of the widely publicized Food and Drug Administration's warnings cautioning that antidepressant use could increase suicidal risk in youth.

methodThis was a retrospective, longitudinal study, modeling prospective surveillance, using the maximized sequential probability ratio test. We used historical data (2000-2010) from 11 health systems in the US Mental Health Research Network. The study cohort included adolescents (ages 10-17 y) and young adults (ages 18-29 y), who were targeted by the warnings, and adults (ages 30-64 y) as a comparison group. Outcome measures were observed and expected events of 2 possible unintended policy outcomes: psychotropic drug poisonings (as a proxy for suicide attempts) and completed suicides.

resultsWe detected statistically significant (P<0.05) signals of excess risk for suicidal behavior in adolescents and young adults within 5-7 quarters of the warnings. The excess risk in psychotropic drug poisonings was consistent with results from a previous, more rigorous interrupted time series analysis but use of the maximized sequential probability ratio test method allows timely detection. While we also detected signals of increased risk of completed suicide in these younger age groups, on its own it should not be taken as conclusive evidence that the policy caused the signal. A statistical signal indicates the need for further scrutiny using rigorous quasi-experimental studies to investigate the possibility of a cause-and-effect relationship.

conclusionsThis was a proof-of-concept study. Prospective, periodic evaluation of administrative health care data using sequential analysis can provide timely population-based signals of effects of health policies. This method may be useful to use as new policies are introduced.

Indexed as

Health PolicyPopulation SurveillanceAdolescentAdultAntidepressive AgentsFemaleHealth BehaviorHumansMaleProspective StudiesRisk-TakingSuicidal IdeationSuicide, AttemptedYoung AdultAntidepressive Agents

Identifiers

PMID29634627
PMCPMC5896783
OpenAlexW2797254907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.